We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byTeresa Hoover
Modified over 5 years ago
Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Ramesh Singh, MD, Matthew L. Williams, MD, Mark S. Slaughter, MD The Annals of Thoracic Surgery Volume 98, Issue 3, Pages (September 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Survival between HeartMate II (HM II) and non–left ventricular assist device (LVAD) groups in unmatched cohort. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Distribution of newly listed patients in HeartMate II (HM II) and non– left ventricular assist device (LVAD) groups by listing year. (MCS = mechanical circulatory support.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Annual mortality rate on waiting list by listing year.The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Survival between HeartMate II (HM II) and non–left ventricular assist device (LVAD) groups in propensity-matched cohort. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,
Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
What Predicts Long-Term Survival After Heart Transplantation
Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device
Benny Weksler, MD, Jennifer L. Sullivan, MD
Triple Bridge to Simultaneous Heart and Kidney Transplantation
Adam N. Protos, MD, Jaimin R. Trivedi, MD, MPH, William M
Implantation of HeartMate II Left Ventricular Assist Device in a Single-Lung Patient Hannah Copeland, MD, Liset Stoletniy, MD, Antoine Sakr, MD, Anees.
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.
Pump Replacement for Left Ventricular Assist Device Failure Can Be Done Safely and Is Associated With Low Mortality Nader Moazami, MD, Carmelo A. Milano,
Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations Jiapeng Huang, MD, PhD, Macarius Donneyong, PhD,
Laura Harvey, MD, Christopher Holley, MD, Samit S
Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,
Dhaval Chauhan, MD, Alexis K
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,
Sharven Taghavi, MD, MPH, Charisse Ward, MD, Senthil N
Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.
Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.
Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation Steven A. Farmer, MD, PhD, Kathleen L. Grady,
© 2023 SlidePlayer.com Inc. All rights reserved.